FibroBiologics FBLG Income Statement (2022-2026)

NASDAQ FBLG
$1.29 +0.10 (+8.40%)
At close: Aug 20, 2026 · 4:00 PM EDT
Income Statement Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Shares Outstanding (Entity) (Quarter) 1.41M1.41M1.41M1.41M1.41M1.64M1.64M1.70M1.75M1.89M2.04M2.41M2.23M3.51M6.66M
Operating items
Research & Development (Quarter) 0.48M0.55M0.57M0.77M0.96M0.97M1.21M1.36M1.78M2.04M2.79M0.80M2.95M1.66M
Selling, General & Administrative (Quarter) 1.79M1.55M1.48M1.71M2.49M2.25M2.14M2.36M2.75M2.45M2.25M1.79M2.12M2.38M
Operating Expenses (Quarter) 2.27M2.09M2.05M2.48M3.45M3.22M3.35M3.71M4.53M4.49M5.04M2.59M5.07M4.03M
Operating Income (Quarter) -2.27M-2.09M-2.05M-2.48M-3.45M-3.22M-3.35M-3.71M-4.53M-4.49M-5.04M-2.59M-5.07M-4.03M
EBIT (Quarter) -2.27M-2.09M-2.05M-2.48M-3.45M-3.22M-3.35M-3.71M-4.53M-4.49M-5.04M-2.59M-5.07M-4.03M
Non-operating items
Interest & Investment Income (Quarter) 0.04M0.07M0.08M0.06M0.10M0.05M0.07M0.03M0.02M0.01M
Other Non Operating Income (Quarter) -0.06M-0.14M0.03M0.00M0.23M-0.45M0.33M-0.85M0.62M-0.00M-0.09M
Non Operating Income (Quarter) -0.01M-0.14M-0.20M2.85M0.61M-0.43M-0.74M-0.65M0.07M-0.08M
Net income details
EBT (Quarter) -2.40M-2.10M-2.05M-2.48M-3.42M-3.16M-6.30M-3.65M-5.84M-5.02M-7.87M-2.76M-7.56M-5.56M
Profit After Tax (Quarter) -2.42M-2.16M-2.19M-9.72M-8.46M0.90M-0.50M-3.10M-4.97M-4.66M-5.78M-3.24M-5.00M-4.12M
Income from Continuing Operations (Quarter) -2.40M-2.10M-2.05M-2.48M-3.42M-3.16M-6.30M-3.65M-5.84M-5.02M-7.87M-2.76M-7.56M-5.56M
Consolidated Net Income (Quarter) -2.40M-2.10M-2.05M-2.48M-3.42M-3.16M-6.30M-3.65M-5.84M-5.02M-7.87M-2.76M-7.56M-5.56M
Income towards Parent Company (Quarter) -2.40M-2.10M-2.05M-2.48M-3.42M-3.16M-6.30M-3.65M-5.84M-5.02M-7.87M-2.76M-7.56M-5.56M
Preferred Dividend Payments (Quarter) -2.57M
Net Income towards Common Stockholders (Quarter) -4.99M-2.16M-2.19M-9.72M-8.46M0.90M-0.50M-3.10M-4.97M-4.66M-7.87M-2.76M-7.56M-5.56M
Additional items
EPS (Basic) (Quarter) -3.53-1.53-1.55-6.88-5.430.55-0.30-1.89-2.71-2.41-3.65-1.24-2.00-0.89
EPS (Diluted) (Quarter) -3.53-1.53-1.55-6.88-5.430.55-0.30-1.89-2.71-2.41-3.65-1.24-2.00-0.89
Shares Outstanding (Quarter) 1.41M1.41M1.41M1.41M1.41M1.56M1.64M1.68M1.64M1.83M1.93M2.15M2.23M3.77M6.27M
Shares Outstanding (Diluted) (Quarter) 1.41M1.41M1.41M1.41M1.41M1.56M1.64M1.68M1.64M1.83M1.93M2.15M2.23M3.77M6.27M
EBITDA (Quarter) -2.27M-2.09M-2.05M-2.48M-3.45M-3.22M-3.35M-3.71M-4.53M-4.49M-5.04M-2.59M-5.07M-4.03M
Interest Expenses (Quarter) 1.27M0.14M0.01M0.00M0.00M0.01M3.02M0.01M1.41M0.58M2.90M0.20M2.51M1.54M